Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic Immune Dysregulation in Neurofibromatosis Type 1: Translational Validation of Atopic Multimorbidity.

The Journal of investigative dermatology·2026
Same author

Splicing isoforms associated with TGFβ-induced myofibroblast activation.

BMC molecular and cell biology·2026
Same author

Proof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models.

Communications biology·2026
Same author

Disruption of Krox20-Notch1 signaling blocks meibomian gland development and homeostasis leading to dry eye disease.

Nature communications·2025
Same author

Development, validation, and preliminary phenotypic characterization of a Col6a3 knockout mouse model targeting exon 3.

Animal models and experimental medicine·2025
Same author

Hair follicle epithelial stem cells contribute to interfollicular epidermis during homeostasis.

JCI insight·2025

Related Experiment Video

Updated: Dec 20, 2025

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

326

Translating current basic research into future therapies for neurofibromatosis type 1.

Jean-Philippe Brosseau1,2, Chung-Ping Liao3, Lu Q Le4,5,6,7

  • 1Department of Dermatology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9069, USA. jean-philippe.brosseau@USherbrooke.ca.

British Journal of Cancer
|May 23, 2020
PubMed
Summary

Neurofibromatosis type 1 (NF1) is a genetic disorder causing tumors. Research explores targeting cellular pathways and microenvironment cells to develop new treatments for NF1 patients.

More Related Videos

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

914
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K

Related Experiment Videos

Last Updated: Dec 20, 2025

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

326
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

914
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K

Area of Science:

  • Oncology
  • Genetics
  • Cell Biology

Background:

  • Neurofibromatosis type 1 (NF1) is an inherited tumor syndrome.
  • It arises from neural crest cells and leads to benign and malignant tumors.
  • Current treatments are limited, with only one drug approved for plexiform neurofibroma.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for NF1.
  • To highlight advances in basic research for novel NF1 treatments.

Main Methods:

  • Review of previous research on targeting signaling pathways (Hippo, JAK/STAT, MAPK, sex hormones).
  • Examination of strategies targeting tumor microenvironment cells (nerve cells, macrophages, mast cells, T cells).
  • Analysis of agents currently in clinical trials for NF1.

Main Results:

  • Inhibiting specific cellular signaling pathways shows therapeutic potential.
  • Targeting the tumor microenvironment offers another avenue for treatment.
  • Several agents are under investigation in clinical trials.

Conclusions:

  • Targeting cellular signaling pathways and the tumor microenvironment are promising strategies for NF1.
  • Recent basic research advances could lead to novel therapeutics.
  • Further research is crucial for developing effective NF1 treatments.